FSD Pharma Inc. (HUGE)
Market Cap | 36.31M |
Revenue (ttm) | 196,259 |
Net Income (ttm) | -39.70M |
Shares Out | 7.06M |
EPS (ttm) | -5.63 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Dividend Yield | n/a |
Trading Day | January 27 |
Last Price | $1.94 |
Previous Close | $2.21 |
Change ($) | -0.27 |
Change (%) | -12.22% |
Day's Open | 2.02 |
Day's Range | 1.78 - 2.02 |
Day's Volume | 1,443,859 |
52-Week Range | 1.36 - 7.39 |
TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announces the following corporate updates. Corporate Update The Company continues to ...
TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq:HUGE) (CSE:HUGE) (“FSD Pharma” or the “Company”) today announced that it will hold its annual meeting of shareholders (the “Meeting”) on June ...
TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announced the dosing of the first patient in its Phase 2a clinical trial of FSD201 (u...
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and we will look ahead at the pot stocks to w...
TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announced its financial results for the third quarter ending September 30, 2020 and p...
TORONTO--(BUSINESS WIRE)-- #FSDPharma--FSD Pharma Inc. (NASDAQ:HUGE) (CSE:HUGE) ("FSD Pharma" or the "Company") today announced that, subject to court certification and other customary conditi...
TORONTO--(BUSINESS WIRE)-- #HUGE--FSD Pharma Inc. (Nasdaq: HUGE) (“FSD Pharma” or the “Company”), today announced the closing of previously announced definitive agreements with investors for t...
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (“FSD Pharma” or the “Company”), today announced that it has entered into definitive agreements with investors for the purchas...
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) announced that the U.S. Food and Drug Administration (“FDA”) has authorized the...
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) today announced that it has submitted to the U.S.
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today reported that management’s discussion and analysis of financi...
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) announces the closing of a previously announced agreement with investors for th...
Vancouver, British Columbia--(Newsfile Corp. - July 31, 2020) - FSD Pharma Inc.
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”), today announced that it has entered into definitive agreements with investors ...
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today announced that it has notified Health Canada of the Company’s...
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (“FSD Pharma” or the “Company”) today announced that it has entered into an Equity Distribution Agreement dated...
Vancouver, British Columbia--(Newsfile Corp. - June 23, 2020) - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FSE: 0K9), a specialty, biotech pharmaceutical R&D company, focused on developing,...
TORONTO--(BUSINESS WIRE)-- #FSDDF--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (“FSD Pharma” or the "Company") today announced favorable topline results from its Phase 1 randomiz...
FSD Pharma Jumps On COVID-19 Trial Progress, And Other News: The Good, Bad And Ugly Of Biopharma
Shares of FSD Pharma tripled Wednesday after the small-cap biotech company announced plans to study a potential coronavirus treatment. The drug is called ultramicronized PEA.
FSD Pharma Inc. (NASDAQ: HUGE) shares absolutely exploded on Wednesday morning after the company received a key update from the U.S.
Shares of FSD Pharma Inc (NASDAQ: HUGE) are advancing strongly Wednesday following an announcement regarding a potential COVID-19 drug.
FSD Pharma Inc (NASDAQ: HUGE) has netted itself more than $7.7 million through the sale of its 12% equity interest in Cannara Biotech Inc (OTC: LOVFF) to a consortium of that included entities...
FSD Pharma Inc (CSE: HUGE) (OTC: FSDDF) said Monday that its Class B Subordinate Voting Shares have been accepted for listing on the NASDAQ Capital Market under the ticker "HUGE.
FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) said Monday it has obtained approval for its Class B subordinate shares to list on the Nasdaq Capital Market.
About HUGE
FSD Pharma, through its subsidiary, FV Pharma Inc., produces medical cannabis in Canada. The company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based treatments for central nervous system disorders and autoimmune diseases of the skin, GI tract, and musculoskeletal system, such as chronic pain. FSD Pharma Inc. has strategic alliance agreements with SciCann Therapeutics Inc., CannTab Therapeutics, and Solarvest BioEnergy Inc. The company was founded in 1998 and is ... [Read more...]
Industry Drug Manufacturers-Specialty & Generic | Founded 1998 |
CEO Raza Bokhari | Employees 17 |
Stock Exchange NASDAQ | Ticker Symbol HUGE |